Filter
8987
Filtered Results: 8987
Text search:
treatment
data
Featured
Recommendations
749
New Publications
2262
Language
Document type
No document type
5093
Studies & Reports
1569
Guidelines
1055
Manuals
434
Strategic & Response Plan
306
Fact sheets
201
Training Material
130
Situation Updates
105
Infographics
34
Resource Platforms
29
Brochures
20
Online Courses
7
Dashboards/Maps
4
Countries / Regions
India
358
Global
347
Kenya
244
South Africa
204
Western and Central Europe
202
Sierra Leone
191
Ethiopia
178
Liberia
166
Nigeria
160
Uganda
154
Nepal
145
Malawi
144
Latin America and the Carribbean
135
Myanmar / Burma
134
Africa
126
Tanzania
124
Zambia
123
Bangladesh
120
Rwanda
109
Syria
104
Ghana
103
Ukraine
101
Eastern Europe
78
Indonesia
77
Namibia
76
Congo, Democratic Republic of
75
Zimbabwe
70
Mozambique
69
South Sudan
68
Philippines
65
Lesotho
64
Brazil
59
Russia
57
Cambodia
52
Guinea
51
South–East Asia Region
51
Haiti
49
Asia
48
East and Southern Africa
44
Yemen
43
Senegal
42
Burkina Faso
42
West and Central Africa
42
Germany
39
Middle East and North Africa
37
Botswana
37
Eastern Europe and Central Asia
30
Venezuela
29
Eswatini/ Swaziland
29
Cameroon
28
Colombia
26
Pakistan
25
Afghanistan
24
Benin
23
Sudan
22
Madagascar
21
Jordan
20
Central African Republic
18
Somalia
18
Lebanon
17
Tajikistan
16
Thailand
16
USA
15
Vietnam
14
China
13
Moldova
13
Iraq
13
Albania
12
Argentina
12
Mali
12
Paraguay
11
Papua New Guinea
11
Georgia
11
Angola
11
Peru
10
Sri Lanka
10
Chile
9
Bolivia
9
Turkey
8
Iran
8
Armenia
8
Western Pacific Region
8
Palestine
8
Laos
7
Niger
7
Burundi
7
Spain
7
Libya
7
Ecuador
7
North Macedonia
6
Gambia
6
Kyrgyzstan
6
Guinea-Bissau
6
North America
6
United Kingdom
6
Southern Africa
6
Egypt
6
Romania
6
Greece
6
Poland
6
Chad
6
Timor Leste/ East Timor
5
Mexico
5
Kazakhstan
5
Malaysia
5
Hungary
5
Jamaica
5
Côte d’Ivoire / Ivory Coast
5
Bhutan
5
Serbia
4
Togo
4
Estonia
4
Morocco
4
Portugal
4
Belarus
4
Switzerland
3
El Salvador
3
Canada
3
Singapore
3
Uzbekistan
3
Mongolia
3
Saudi Arabia
3
Japan
3
Mauritius
3
Tunisia
3
Azerbaijan
3
Djibouti
3
Qatar
2
Bulgaria
2
Italy
2
Croatia
2
Lithuania
2
Gabon
2
Turkmenistan
2
Slovakia
2
Honduras
2
North Korea
1
Australia
1
Fiji
1
Austria
1
Vanuatu
1
Mauritania
1
Ireland
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
Algeria
1
French Guyana
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3294
Clinical Guidelines
697
Public Health
476
Key Resources
423
Women & Child Health
412
Capacity Building
162
Pharmacy & Technologies
85
Annual Report MEDBOX
3
Toolboxes
HIV
838
Mental Health
793
COVID-19
705
TB
594
NTDs
353
AMR
294
Ebola & Marburg
266
Disability
264
Rapid Response
247
Caregiver
239
Conflict
233
Planetary Health
214
NCDs
198
Pharmacy
169
Refugee
168
Global Health Education
117
Natural Hazards
93
Health Financing Toolbox
80
Cholera
55
Zika
52
Specific Hazards
48
Polio
33
Social Ethics
20
Typhoon
5
South Sudan
2
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
Analysis
Accessed: 14.03.2019
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing and treatment, and linkages to services for sexually transmitted infections, viral hepatitis, tuberculosis and cervical cancer. The guidelines also...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
The estimated share of people at risk of schistosomiasis who require preventive chemotherapy.
The estimated number of people who are at risk of schistosomiasis who require preventive treatment
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence ...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
Latest update: 29 De 2021. Slideset updated regularly to include the latest data and guidance on non-therapeutic and therapeutic treatments for COVID-19, including authorized and investigational agents.
The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine developers and making use of real-world data to monitor the safety and effectiveness of medicines use...
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed drugs produced better outcomes and fewer deaths than older treatments.
The meta-analysis...
Global and Regional Data 1 December 2021; The 90–90–90 targets were missed, but not by much. At the end of 2020, 84% of people living with HIV knew their HIV status, 87% of people living with HIV who knew their HIV status were accessing antiretroviral therapy, and 90% of people on treatment were...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with tuberculosis treatment failure in the central east ...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Barriers to the prompt and effective diagnosis and treatment of malaria exist at both the community and health facility level. Household surveys measure malaria case management at the population level with standard indicators that assess treatment-seeking behavior, access to diagnostic testing, and ...
Slideset updated regularly to reflect the state of the COVID-19 pandemic and to include the latest data and guidance on best practices for diagnosis and management; topics include global epidemiology, screening and diagnosis, natural history and clinical presentation, disease severity, medical manag...
